Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series

Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series

(1) Background: This study aims to assess the safety and efficacy of fractionated SRT (fSRT) and pertuzumab–trastuzumab (PT) in patients with breast cancer brain metastases (BCBM). (2) Methods: Patients with HER2+ BCBM who received FSRT from 2015 to 2019 were identified. Patients were included if th...

Full description

Bibliographic Details
Main Authors: Edy Ippolito, Sonia Silipigni, Paolo Matteucci, Carlo Greco, Francesco Pantano, Giuliana D’Auria, Carlo Cosimo Quattrocchi, Barnaba Floreno, Michele Fiore, Teresa Gamucci, Giuseppe Tonini, Sara Ramella
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Cancers
Subjects:
SRT
breast cancer
dual blockade
trastuzumab
pertuzumab
Online Access:https://www.mdpi.com/2072-6694/14/2/303

Internet

https://www.mdpi.com/2072-6694/14/2/303

Similar Items